# StimLabs, LLC – FDA Inspection, Apr 7, 2022

Source: https://www.keypedia.com/records/fda_inspections/stimlabs-llc/f1f9b7ff-d9b9-41a7-ae84-e4d1d16784bc
Source feed: FDA_Inspections

> FDA inspection 1167413 of StimLabs, LLC, April 07, 2022. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167413
- Company Name: StimLabs, LLC
- Inspection Date: 2022-04-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1330752 - 2026-08-06
- FDA Inspection 1038774 - 2018-01-02

Company: https://www.keypedia.com/companies/stimlabs-llc/def0d701-7a5e-4e9b-b6bb-bdcd6de509bf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d